Integrated care for migraine and chronic tension-type headaches: A prospective observational study
This prospective observational study aimed to investigate the effects of an interdisciplinary multimodal integrated care program in patients with chronic migraine and/or tension-type headache. Patients (n = 158) underwent inpatient, outpatient and/or semi-stationary treatment including conventional...
Saved in:
Published in | Complementary therapies in clinical practice Vol. 36; pp. 1 - 6 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.08.2019
Elsevier Science Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This prospective observational study aimed to investigate the effects of an interdisciplinary multimodal integrated care program in patients with chronic migraine and/or tension-type headache.
Patients (n = 158) underwent inpatient, outpatient and/or semi-stationary treatment including conventional as well as complementary headache treatment. Headache frequency was defined as the primary outcome; secondary outcomes included pain (VAS, PPS), medication use, quality of life (SF-36), function (HDI, PSFS), depression and anxiety (HADS), and pain self-efficacy (PSEQ).
Headache frequency decreased from 17.0 ± 8.8 days/month at treatment start to 11.4 ± 9.2 at treatment end and to 10.6 ± 9.3 at 6-month follow-up (p < 0.001). All other outcome measures also improved across the course of the study (all p < 0.001).
An integrated care approach based on integrative medicine improved headache symptoms and functioning in patients with chronic migraine and/or tension-type headache. Interdisciplinary multimodal treatment approaches seem to adequately address the specific treatment needs of headache patients.
•An integrated care program for patients with migraine or tension-type headache was established.•The program encompassed inpatient and outpatient treatment including conventional and complementary medicine approaches.•Headache frequency decreased from 17.0 ± 8.8 days/month before treatment to 10.6 ± 9.3 days/month at 6-month follow-up.•The program further improved pain intensity, medication use, quality of life, function, depression, anxiety, self-efficacy. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
ISSN: | 1744-3881 1873-6947 |
DOI: | 10.1016/j.ctcp.2019.04.001 |